Dendritic cells are less susceptible to human immunodeficiency virus type 2 (HIV-2) infection than to HIV-1 infection. 2007

Melody G Duvall, and Karin Loré, and Hetty Blaak, and David A Ambrozak, and William C Adams, and Kathlyn Santos, and Christof Geldmacher, and John R Mascola, and Andrew J McMichael, and Assan Jaye, and Hilton C Whittle, and Sarah L Rowland-Jones, and Richard A Koup
MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, United Kingdom.

Human immunodeficiency virus type 1 (HIV-1) infection of dendritic cells (DCs) has been documented in vivo and may be an important contributor to HIV-1 transmission and pathogenesis. HIV-1-specific CD4(+) T cells respond to HIV antigens presented by HIV-1-infected DCs and in this process become infected, thereby providing a mechanism through which HIV-1-specific CD4(+) T cells could become preferentially infected in vivo. HIV-2 disease is attenuated with respect to HIV-1 disease, and host immune responses are thought to be contributory. Here we investigated the susceptibility of primary myeloid DCs (mDCs) and plasmacytoid DCs (pDCs) to infection by HIV-2. We found that neither CCR5-tropic primary HIV-2 isolates nor a lab-adapted CXCR4-tropic HIV-2 strain could efficiently infect mDCs or pDCs, though these viruses could infect primary CD4(+) T cells in vitro. HIV-2-exposed mDCs were also incapable of transferring virus to autologous CD4(+) T cells. Despite this, we found that HIV-2-specific CD4(+) T cells contained more viral DNA than memory CD4(+) T cells of other specificities in vivo. These data suggest that either infection of DCs is not an important contributor to infection of HIV-2-specific CD4(+) T cells in vivo or that infection of DCs by HIV-2 occurs at a level that is undetectable in vitro. The frequent carriage of HIV-2 DNA within HIV-2-specific CD4(+) T cells, however, does not appear to be incompatible with preserved numbers and functionality of HIV-2-specific CD4(+) T cells in vivo, suggesting that additional mechanisms contribute to maintenance of HIV-2-specific CD4(+) T-cell help in vivo.

UI MeSH Term Description Entries
D007156 Immunologic Memory The altered state of immunologic responsiveness resulting from initial contact with antigen, which enables the individual to produce antibodies more rapidly and in greater quantity in response to secondary antigenic stimulus. Immune Memory,Immunological Memory,Memory, Immunologic,Immune Memories,Immunologic Memories,Immunological Memories,Memory, Immune,Memory, Immunological
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D003713 Dendritic Cells Specialized cells of the hematopoietic system that have branch-like extensions. They are found throughout the lymphatic system, and in non-lymphoid tissues such as SKIN and the epithelia of the intestinal, respiratory, and reproductive tracts. They trap and process ANTIGENS, and present them to T-CELLS, thereby stimulating CELL-MEDIATED IMMUNITY. They are different from the non-hematopoietic FOLLICULAR DENDRITIC CELLS, which have a similar morphology and immune system function, but with respect to humoral immunity (ANTIBODY PRODUCTION). Dendritic Cells, Interdigitating,Interdigitating Cells,Plasmacytoid Dendritic Cells,Veiled Cells,Dendritic Cells, Interstitial,Dendritic Cells, Plasmacytoid,Interdigitating Dendritic Cells,Interstitial Dendritic Cells,Cell, Dendritic,Cell, Interdigitating,Cell, Interdigitating Dendritic,Cell, Interstitial Dendritic,Cell, Plasmacytoid Dendritic,Cell, Veiled,Cells, Dendritic,Cells, Interdigitating,Cells, Interdigitating Dendritic,Cells, Interstitial Dendritic,Cells, Plasmacytoid Dendritic,Cells, Veiled,Dendritic Cell,Dendritic Cell, Interdigitating,Dendritic Cell, Interstitial,Dendritic Cell, Plasmacytoid,Interdigitating Cell,Interdigitating Dendritic Cell,Interstitial Dendritic Cell,Plasmacytoid Dendritic Cell,Veiled Cell
D004279 DNA, Viral Deoxyribonucleic acid that makes up the genetic material of viruses. Viral DNA
D005434 Flow Cytometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015496 CD4-Positive T-Lymphocytes A critical subpopulation of T-lymphocytes involved in the induction of most immunological functions. The HIV virus has selective tropism for the T4 cell which expresses the CD4 phenotypic marker, a receptor for HIV. In fact, the key element in the profound immunosuppression seen in HIV infection is the depletion of this subset of T-lymphocytes. T4 Cells,T4 Lymphocytes,CD4-Positive Lymphocytes,CD4 Positive T Lymphocytes,CD4-Positive Lymphocyte,CD4-Positive T-Lymphocyte,Lymphocyte, CD4-Positive,Lymphocytes, CD4-Positive,T-Lymphocyte, CD4-Positive,T-Lymphocytes, CD4-Positive,T4 Cell,T4 Lymphocyte
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015498 HIV-2 An HIV species related to HIV-1 but carrying different antigenic components and with differing nucleic acid composition. It shares serologic reactivity and sequence homology with the simian Lentivirus SIMIAN IMMUNODEFICIENCY VIRUS and infects only T4-lymphocytes expressing the CD4 phenotypic marker. HTLV-IV,Human T-Lymphotropic Virus Type IV,Human immunodeficiency virus 2,LAV-2,HIV-II,Human Immunodeficiency Virus Type 2,Human T Lymphotropic Virus Type IV,Immunodeficiency Virus Type 2, Human,SBL-6669

Related Publications

Melody G Duvall, and Karin Loré, and Hetty Blaak, and David A Ambrozak, and William C Adams, and Kathlyn Santos, and Christof Geldmacher, and John R Mascola, and Andrew J McMichael, and Assan Jaye, and Hilton C Whittle, and Sarah L Rowland-Jones, and Richard A Koup
July 2001, Journal of virology,
Melody G Duvall, and Karin Loré, and Hetty Blaak, and David A Ambrozak, and William C Adams, and Kathlyn Santos, and Christof Geldmacher, and John R Mascola, and Andrew J McMichael, and Assan Jaye, and Hilton C Whittle, and Sarah L Rowland-Jones, and Richard A Koup
December 1987, Antimicrobial agents and chemotherapy,
Melody G Duvall, and Karin Loré, and Hetty Blaak, and David A Ambrozak, and William C Adams, and Kathlyn Santos, and Christof Geldmacher, and John R Mascola, and Andrew J McMichael, and Assan Jaye, and Hilton C Whittle, and Sarah L Rowland-Jones, and Richard A Koup
June 2010, Nihon rinsho. Japanese journal of clinical medicine,
Melody G Duvall, and Karin Loré, and Hetty Blaak, and David A Ambrozak, and William C Adams, and Kathlyn Santos, and Christof Geldmacher, and John R Mascola, and Andrew J McMichael, and Assan Jaye, and Hilton C Whittle, and Sarah L Rowland-Jones, and Richard A Koup
November 1992, The Journal of investigative dermatology,
Melody G Duvall, and Karin Loré, and Hetty Blaak, and David A Ambrozak, and William C Adams, and Kathlyn Santos, and Christof Geldmacher, and John R Mascola, and Andrew J McMichael, and Assan Jaye, and Hilton C Whittle, and Sarah L Rowland-Jones, and Richard A Koup
April 2002, The Journal of experimental medicine,
Melody G Duvall, and Karin Loré, and Hetty Blaak, and David A Ambrozak, and William C Adams, and Kathlyn Santos, and Christof Geldmacher, and John R Mascola, and Andrew J McMichael, and Assan Jaye, and Hilton C Whittle, and Sarah L Rowland-Jones, and Richard A Koup
January 1995, Advances in experimental medicine and biology,
Melody G Duvall, and Karin Loré, and Hetty Blaak, and David A Ambrozak, and William C Adams, and Kathlyn Santos, and Christof Geldmacher, and John R Mascola, and Andrew J McMichael, and Assan Jaye, and Hilton C Whittle, and Sarah L Rowland-Jones, and Richard A Koup
May 1994, Journal of virology,
Melody G Duvall, and Karin Loré, and Hetty Blaak, and David A Ambrozak, and William C Adams, and Kathlyn Santos, and Christof Geldmacher, and John R Mascola, and Andrew J McMichael, and Assan Jaye, and Hilton C Whittle, and Sarah L Rowland-Jones, and Richard A Koup
June 1996, AIDS (London, England),
Melody G Duvall, and Karin Loré, and Hetty Blaak, and David A Ambrozak, and William C Adams, and Kathlyn Santos, and Christof Geldmacher, and John R Mascola, and Andrew J McMichael, and Assan Jaye, and Hilton C Whittle, and Sarah L Rowland-Jones, and Richard A Koup
January 1995, Annales de dermatologie et de venereologie,
Melody G Duvall, and Karin Loré, and Hetty Blaak, and David A Ambrozak, and William C Adams, and Kathlyn Santos, and Christof Geldmacher, and John R Mascola, and Andrew J McMichael, and Assan Jaye, and Hilton C Whittle, and Sarah L Rowland-Jones, and Richard A Koup
March 1996, Ugeskrift for laeger,
Copied contents to your clipboard!